Human AGGF1(Angiogenic Factor with G Patch and FHA Domains 1) CLIA Kit

The Human AGGF1 CLIA Kit is a highly reliable and accurate diagnostic tool designed for the detection and quantification of AGGF1 (Angiogenic Factor with G Patch and FHA Domains 1) in human serum, plasma, and other biological fluids. This kit is based on the Chemiluminescent Immunoassay (CLIA) technology, which offers superior sensitivity and specificity compared to other conventional immunoassay methods.

The kit contains all the necessary components, including pre-coated microplates, assay buffer, detection reagents, and standards, to perform the assay in a simple and efficient manner. The assay procedure involves the binding of AGGF1 present in the sample to the pre-coated microplate, followed by the addition of detection reagents that generate a chemiluminescent signal proportional to the amount of AGGF1 present in the sample.

The Human AGGF1 CLIA Kit is intended for research use only and is not intended for diagnostic or therapeutic purposes. It is suitable for use in various research applications, including the study of angiogenesis, cancer, and cardiovascular diseases. The kit is manufactured under strict quality control standards to ensure consistent and reliable results. With its high sensitivity, specificity, and ease of use, the Human AGGF1 CLIA Kit is an essential tool for researchers in the field of biomedical research.